In addition, since AST and ALT may normalize with sustained virologic response, the FIB-4 score may be lower unless the patient has underlying non-alcoholic fatty liver disease (NAFLD) and/or very low platelets. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.